Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2016-09-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbrc.2016.09.002PMID 27592554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2.

  2014cited by this paper
• Cancer stem cells in the development of liver cancer.

  2013cited by this paper
• Metabolic targets for cancer therapy

  2013cited by this paper
• Liver X receptor and peroxisome proliferator‐activated receptor as integrators of lipid homeostasis and immunity

  2012cited by this paper
• Hepatocellular carcinoma

  2012cited by this paper
• Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside

  2012cited by this paper
• Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma

  2012cited by this paper
• Targeting cancer metabolism: a therapeutic window opens

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response

  2011cited by this paper
• Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma.

  2010cited by this paper
• Hepatocellular carcinoma: a global view

  2010cited by this paper
• Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma.

  2009cited by this paper
• ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.

  2008cited by this paper
• Hepatocellular carcinoma development in cirrhosis.

  2007cited by this paper
• Hepatocellular carcinoma pathogenesis: from genes to environment

  2006cited by this paper
• Adipocyte differentiation from the inside out

  2006cited by this paper
• Hepatocellular carcinoma: molecular pathways and new therapeutic targets.

  2005cited by this paper
• Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling

  2004cited by this paper
• The Krüppel-like Factor KLF2 Inhibits Peroxisome Proliferator-activated Receptor-γ Expression and Adipogenesis*

  2003cited by this paper
• Molecular pathogenesis of human hepatocellular carcinoma

  2002cited by this paper
• Genetic mechanisms of hepatocarcinogenesis

  2002cited by this paper
• Analysis of ODC and c-myc gene expression in hepatocellular carcinoma by in situ hybridization and immunohistochemistry.

  1993cited by this paper

• Single-nucleus multiomics reveals the gene regulatory networks underlying sex determination of murine primordial germ cells

  2025cites this paper
• Metabolic syndrome promotes endometrial cancer by Oleic acid-mediated polyamine accumulation

  2025cites this paper
• IP-SNPs-seq links noncoding risk alleles to lineage transcription factor programs in prostate cancer

  2025cites this paper
• Ornithine decarboxylase 1 modulation regulates plasma membrane integrity and associated gene networks under glucotoxicity and lipotoxicity stress: An in vitro study.

  2025cites this paper
• [Long noncoding RNA HClnc1 promotes proliferation and migration of liver cancer cells by targeting RBBP5/KAT2B complex to enhance ODC1 transcription].

  2025cites this paper
• Uncovering the mechanism of Buyang Huanwu decoction in regulating mitochondrial dysfunction to alleviate atherosclerosis: BTK, PREPL, and P2RX7 proteins play key roles.

  2025cites this paper
• Salmonella Typhimurium employs spermidine to exert protection against ROS-mediated cytotoxicity and rewires host polyamine metabolism to ameliorate its survival in macrophages

  2024cites this paper
• Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria.

  2024cites this paper
• Single-nucleus multiomics reveals the gene-regulatory networks underlying sex determination of murine primordial germ cells

  2024cites this paper
• The functional role of circular RNAs in the pathogenesis of retinoblastoma: a new potential biomarker and therapeutic target?

  2023cites this paper
• A polyamine metabolism risk signature for predicting the prognosis and immune therapeutic response of kidney cancer

  2023cites this paper
• Salmonella Typhimurium employ spermidine to exert protection against ROS-mediated cytotoxicity and rewires host polyamine metabolism to ameliorate its survival in macrophages

  2023cites this paper
• The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy

  2023cites this paper
• Identification of a polyamine-related signature and six novel prognostic biomarkers in oral squamous cell carcinoma

  2023cites this paper
• SP and KLF Transcription Factors in Cancer Metabolism

  2022cites this paper
• Quantitative Metabolomics to Explore the Role of Plasma Polyamines in Colorectal Cancer

  2022cites this paper
• Investigation of the Therapeutic Effect of Total Alkaloids of Corydalis saxicola Bunting on CCl4-Induced Liver Fibrosis in Rats by LC/MS-Based Metabolomics Analysis and Network Pharmacology

  2022cites this paper
• Circular RNA circ_0003028 regulates cell development through modulating miR-498/ornithine decarboxylase 1 axis in hepatocellular carcinoma

  2022cites this paper
• Radiosynthesis and evaluation of N5-(2-18F-fluoropropanyl) ornithine as a potential agent for tumor PET imaging.

  2021cites this paper
• Metabolism and function of polyamines in cancer progression.

  2021cites this paper
• Cucurbit[7]uril as a Broad-Spectrum Antiviral Agent against Diverse RNA Viruses

  2021cites this paper
• Bioinformatics analysis of different candidate genes involved in hepatocellular carcinoma induced by HepG2 cells or tumor cells of patients

  2020cites this paper
• Vitamin B6 Fuels Acute Myeloid Leukemia Growth.

  2020cites this paper
• FATS regulates polyamine biosynthesis by promoting ODC degradation in an ERβ-dependent manner in non-small-cell lung cancer

  2020cites this paper
• Simultaneous Inhibition of Ornithine Decarboxylase 1 and Pyruvate Kinase M2 Exerts Synergistic Effects Against Hepatocellular Carcinoma Cells

  2020cites this paper
• SKP2, positively regulated by circ_ODC1/miR‐422a axis, promotes the proliferation of retinoblastoma

  2020cites this paper
• Analyzing the Effects of Intrauterine Hypoxia on Gene Expression in Oocytes of Rat Offspring by Single Cell Transcriptome Sequencing

  2019cites this paper
• ODC1 promotes proliferation and mobility via the AKT/GSK3β/β-catenin pathway and modulation of acidotic microenvironment in human hepatocellular carcinoma

  2019cites this paper
• A distinctively expressed long noncoding RNA, RP11‐466I1.1, may serve as a prognostic biomarker in hepatocellular carcinoma

  2018cites this paper
• The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor Cells

  2018cites this paper
• Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism

  2018cites this paper
• ODC1 inhibits the inflammatory response and ROS-induced apoptosis in macrophages.

  2018cites this paper
• Lipid metabolism and carcinogenesis, cancer development.

  2018cites this paper
• Synthesis and Deployment of an Elusive Fluorovinyl Cation Equivalent: Access to Quaternary α-(1'-Fluoro)vinyl Amino Acids as Potential PLP Enzyme Inactivators.

  2017cites this paper
• Aspirin suppresses the abnormal lipid metabolism in liver cancer cells via disrupting an NFκB-ACSL1 signaling.

  2017cites this paper